ClinicalTrials.gg
CompletedNCT07905326Updated Oct 29, 2026

Muscle Architecture, Stiffness, and Neuromuscular Activation in Unilateral Adhesive Capsulitis

An observational study in Adhesive Capsulitis of the Shoulder, sponsored by Ankara Yildirim Beyazıt University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Ankara Yildirim Beyazıt University · Observational

Updated Oct 29, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
32
Ages
40 Years to 70 Years
Sex
All
01

Study summary

This prospective observational study examined muscle structure, stiffness, and activation in adults aged 40 to 70 years with unilateral adhesive capsulitis. Thirty-two participants completed a single assessment of both shoulders using ultrasound, shear-wave elastography, surface electromyography, and shoulder-function questionnaires. The affected shoulder was compared with the asymptomatic contralateral shoulder, and affected-side findings were compared between pain-dominant (freezing) and stiffness-dominant (frozen) phases. The study did not assign a treatment or intervention.

Read the detailed description

This was a prospective, single-center observational study with a cross-sectional assessment and within-participant comparison of the affected and asymptomatic contralateral shoulders. Adults aged 40-70 years with unilateral adhesive capsulitis were recruited consecutively from the Department of Orthopedics and Traumatology outpatient clinic at Ankara Etlik City Hospital, Ankara, Türkiye, from July 2024 through February 2026. Thirty-two participants completed all assessments.

Participants were classified as being in the freezing phase (visual analog scale pain score 6-10; n=15) or frozen phase (score 0-5; n=17). No treatment was assigned by the study. Bilateral ultrasound was used to measure muscle thickness, fascicle length, physiological cross-sectional area, and pennation angle of the supraspinatus, infraspinatus, teres minor, and anterior, middle, and posterior deltoid. Shear-wave elastography was used to measure muscle Young's modulus. Surface electromyography was recorded during dumbbell scaption and normalized to maximal voluntary isometric contraction.

Shoulder function was assessed with the Constant-Murley Score, UCLA Shoulder Scale, ASES, DASH, QuickDASH, and Oxford Shoulder Score. Primary analyses compared the affected and contralateral shoulders. Secondary analyses compared affected-side measures between phases and examined associations between muscle measures and function scores. All assessments were performed in a single session before initiation of any new treatment.

02

Conditions studied

  • Adhesive Capsulitis of the Shoulder

Browse trials for

Keywords

  • Frozen shoulder
  • Adhesive capsulitis
  • Rotator cuff
  • Deltoid
  • Muscle architecture
  • Shear-wave elastography
  • Surface electromyography
03

In context

Bursitis

383 studies on the registry are indexed under Bursitis; 111 are open to participants now.

This study's enrollment of 32 is below the median of 50 across 29 observational studies indexed under Bursitis.

Browse Bursitis studies →

Lead sponsor

Ankara Yildirim Beyazıt University is the lead sponsor of 241 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults aged 40-70 years with unilateral adhesive capsulitis, consecutively recruited from the Orthopedics and Traumatology outpatient clinic at Ankara Etlik City Hospital, Ankara, Türkiye. Thirty-two participants were enrolled and completed the single-session assessment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 40-70 years.
  • Unilateral adhesive capsulitis meeting the study diagnostic criteria.
  • Shoulder pain for more than 3 months.
  • Restriction of active and passive forward flexion to \<100°, external rotation to \<10°, and internal rotation to below the L5 spinous level.
  • No abnormality on standard anteroposterior and axillary radiographs.
  • Asymptomatic contralateral shoulder with full active range of motion and no history of shoulder surgery, fracture, dislocation, or adhesive capsulitis.
  • Ability to understand instructions, perform resisted shoulder tasks and maximal voluntary contractions, and complete questionnaires.

Exclusion criteria

Exclusion Criteria:

  • Bilateral adhesive capsulitis.
  • Full- or partial-thickness rotator cuff tear on ultrasound, calcific tendinitis, or glenohumeral osteoarthritis.
  • Previous shoulder surgery or fracture on either side.
  • injection, hydrodilatation, or manipulation under anesthesia of the affected shoulder within the previous 3 months.
  • Neurologic disorder affecting the upper limbs or neuromuscular disease.
  • Inflammatory arthritis or systemic disease affecting muscle properties.
  • Skin lesions or allergy precluding electrode placement or ultrasound gel application.
  • Cognitive impairment preventing cooperation with the testing protocol.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
32 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Freezing Phase

    Participants with unilateral adhesive capsulitis classified in the freezing phase based on a visual analog scale pain score of 6-10. Actual enrollment: 15 participants.

  • Frozen Phase

    Participants with unilateral adhesive capsulitis classified in the frozen phase based on a visual analog scale pain score of 0-5. Actual enrollment: 17 participants.

06

What researchers measure

Primary outcomes

  1. Side-to-Side Difference in Muscle Thickness

    Ultrasound muscle thickness (cm) in the supraspinatus, infraspinatus, teres minor, and anterior, middle, and posterior deltoid; compare the affected shoulder with the asymptomatic contralateral shoulder.

    Time frame: Baseline (single assessment at the initial study visit)

  2. Side-to-Side Difference in Fascicle Length

    Ultrasound fascicle length (cm) in the supraspinatus, infraspinatus, teres minor, and anterior, middle, and posterior deltoid; compare the affected shoulder with the asymptomatic contralateral shoulder.

    Time frame: Baseline (single assessment at the initial study visit)

  3. Side-to-Side Difference in Physiological Cross-Sectional Area

    Ultrasound-derived physiological cross-sectional area (PCSA; cm²) for the supraspinatus, infraspinatus, teres minor, and deltoid subregions; compare the affected shoulder with the contralateral shoulder.

    Time frame: Baseline (single assessment at the initial study visit)

  4. Side-to-Side Difference in Pennation Angle

    Ultrasound pennation angle (degrees) for the supraspinatus, infraspinatus, teres minor, and deltoid subregions; compare the affected shoulder with the contralateral shoulder.

    Time frame: Baseline (single assessment at the initial study visit)

  5. Side-to-Side Difference in Shear-Wave Elastography Stiffness

    Mean Young's modulus (kPa) from three acquisitions for each muscle; compare the affected shoulder with the asymptomatic contralateral shoulder.

    Time frame: Baseline (single assessment at the initial study visit)

  6. Side-to-Side Difference in Normalized Surface EMG Activation

    Mean root-mean-square amplitude during dumbbell scaption, normalized to maximal voluntary isometric contraction (%MVIC), for the supraspinatus, infraspinatus, teres minor, and deltoid subregions; compare the affected shoulder with the contralateral shoulder.

    Time frame: Baseline (single assessment at the initial study visit)

Secondary outcomes

  1. Difference in Affected-Side Muscle Parameters Between Disease Phases

    Compare affected-side muscle architecture, shear-wave elastography stiffness, and normalized EMG parameters between the freezing phase (VAS 6-10; n=15) and frozen phase (VAS 0-5; n=17).

    Time frame: Baseline (single assessment at the initial study visit)

  2. Association Between Affected-Side Muscle Parameters and Shoulder Function

    Assess correlations between affected-side muscle architecture, shear-wave elastography stiffness, normalized EMG, and the Constant-Murley Score, UCLA Shoulder Scale, ASES, DASH, QuickDASH, and Oxford Shoulder Score.

    Time frame: Baseline (single assessment at the initial study visit)

07

Study locations

1 site
  • University of Health Sciences
    Ankara, Kecioren 06010, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect participants' privacy and confidentiality. Only aggregate data are reported.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2024 to primary completion in Oct 2024, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2026
First posted
Oct 29, 2026
StartActual
Aug 24, 2024
Primary completionActual
Oct 10, 2024
CompletionActual
Nov 10, 2024
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07905326
Responsible party
caglar soylu (Associate Professor, Ankara Yildirim Beyazıt University) — Principal investigator
First posted
Oct 29, 2026
Start date
Aug 24, 2024
Primary completion
Oct 10, 2024
Completion
Nov 10, 2024
Last update
Oct 29, 2026

Study contacts

Ali Şahin, MD
principal investigator · Acibadem Ankara Hospital
Yasin Erdogan, MD
study chair · Ankara Etlik City Hospital
Yunus Kesik, MD
study chair · Ankara Etlik City Hospital
Necmiye Un Yildirim, PT, PhD
study chair · Saglik Bilimleri Universitesi
Ahmet Firat, MD
study chair · VM Medical Park Ankara Hospital; Istinye University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion